Drugs / ATO
last change Oct 2021 re-read 2 minutes ago

ATO

Developed for
acute promyelocytic leukemia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02200978 Comparator Sep 2011 → Oct 2021 acute promyelocytic leukemia South China Children's Leukemia Group Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ATO ClinicalTrials.gov intervention name — accepted as the source's own label NCT02200978
Route Intravenous “Given IV” NCT02200978